These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9312546)

  • 1. [Care Study. Secondary prevention after myocardial infarct in moderately elevated total cholesterol].
    Bönner G
    Fortschr Med; 1997 Jun; 115(17):57-8. PubMed ID: 9312546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study].
    Otterstad JE; Hexeberg E; Holme I; Hjermann I
    Tidsskr Nor Laegeforen; 1997 Jun; 117(16):2341-4. PubMed ID: 9265282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ezetimib--the first selective cholesterol resorption inhibitors. Strengthening of statins].
    MMW Fortschr Med; 2002 Nov; 144(48):52-3. PubMed ID: 12532546
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
    Tsevat J; Kuntz KM; Orav EJ; Weinstein MC; Sacks FM; Goldman L
    Am Heart J; 2001 May; 141(5):727-34. PubMed ID: 11320359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High cholesterol levels are discriminated by new therapeutic recommendations].
    Olsson AG
    Lakartidningen; 2000 Apr; 97(16):1995-6. PubMed ID: 10826361
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 8. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Socioeconomic aspects of therapy of cardiovascular diseases].
    Lauterbach KW
    Herz; 2000 Aug; 25(5):473-5. PubMed ID: 10992995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilipidemic agents].
    Irsigler K; Flegel U
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):334-40. PubMed ID: 5148890
    [No Abstract]   [Full Text] [Related]  

  • 12. Lower cholesterol to lower heart risk.
    Clark WL
    Diabetes Self Manag; 2004; 21(3):19, 21-2, 25. PubMed ID: 15206362
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study].
    Szucs TD; Bertel O; Darioli R; Gutzwiller F; Mordasini R
    Praxis (Bern 1994); 2000 Apr; 89(18):745-52. PubMed ID: 10823012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids].
    Arnheim K
    MMW Fortschr Med; 2000 Jun; 142(24):18. PubMed ID: 10895577
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and treatment of hyperlipoidaemias].
    Wolfram G
    Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214
    [No Abstract]   [Full Text] [Related]  

  • 19. The detection and management of dyslipidaemia in children and adolescents.
    Ose L; Tonstad S
    Acta Paediatr; 1995 Nov; 84(11):1213-5. PubMed ID: 8580613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.